UCLA Clinical Translational Science Institute IRB Group

This MOU represents a reciprocal IRB agreement and, therefore, allows an IRB at any one of the institutions below to rely on one of the other institution’s IRB for review and approval of human subjects research for collaborative research, under certain specified conditions:

• Burns and Allen Research Institute at Cedars-Sinai Medical Center (Cedars-Sinai),
• Charles R. Drew University of Medicine and Science (CDU),
• Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed),
• UCLA, and
• University of Southern California (USC) (added in Spring 2015)

Additional information is available at the following links:

• CTSI Reviewing IRB Decision Tree

For more information, please contact irbreliance@research.ucla.edu.